Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Fundamental biomaterials : polymers / / Sabu Thomas, Preetha Balakrishnan, Sreekala M. S
| Fundamental biomaterials : polymers / / Sabu Thomas, Preetha Balakrishnan, Sreekala M. S |
| Autore | Thomas Sabu |
| Pubbl/distr/stampa | Cambridge, Massachusetts : , : Woodhead Publishing, , 2018 |
| Descrizione fisica | 1 online resource (339 pages) : illustrations |
| Disciplina | 572.33 |
| Collana | Woodhead Publishing Series in Biomaterials |
| Soggetto topico |
Biopolymers
Biotechnology |
| ISBN |
0-08-102195-X
0-08-102194-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583499403321 |
Thomas Sabu
|
||
| Cambridge, Massachusetts : , : Woodhead Publishing, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fundamental biomaterials : ceramics / / Sabu Thomas, Preetha Balakrishnan, M.S. Sreekala
| Fundamental biomaterials : ceramics / / Sabu Thomas, Preetha Balakrishnan, M.S. Sreekala |
| Autore | Thomas Sabu |
| Pubbl/distr/stampa | Duxford, Kidlington, England ; ; Cambridge, Massachusetts : , : Woodhead Publishing, , 2018 |
| Descrizione fisica | 1 online resource (500 pages) : illustrations |
| Disciplina | 610.28 |
| Collana | Woodhead Publishing Series in Biomaterials |
| Soggetto topico |
Ceramics in medicine
Biomedical materials |
| ISBN | 0-08-102204-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583040303321 |
|
Thomas Sabu
|
||
| Duxford, Kidlington, England ; ; Cambridge, Massachusetts : , : Woodhead Publishing, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fundamental biomaterials : metals / / edited by Preetha Balakrishnan, Sreekala M S, Sabu Thomas
| Fundamental biomaterials : metals / / edited by Preetha Balakrishnan, Sreekala M S, Sabu Thomas |
| Pubbl/distr/stampa | Duxford, Kidlington England ; ; Cambridge, Massachusetts : , : WoodHead Publishing, , 2018 |
| Descrizione fisica | 1 online resource (46 pages) |
| Disciplina | 610.28 |
| Soggetto topico |
Biomedical materials
Metals in medicine |
| ISBN | 0-08-102206-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: ; 1. Metallic biomaterials: State of the art and new challenges / Dr. J. Wilson -- ; 1.1. Introduction -- ; 1.2. Types of biomaterials -- ; 1.3. Behaviors of biomaterials -- ; 1.4. Bioactivity of materials -- ; 1.5. Applications of biomaterials -- ; 1.6. Metallic biology origin and its developments -- ; 1.7. Stainless steel -- ; 1.8. Cobalt-based implants -- ; 1.9. Titanium-based implants -- ; 1.10. Tantalum-based implants -- ; 1.11. Mg-based alloys -- ; 1.12. Zr-and Pd-based alloys -- ; 1.13. Conclusions -- Acknowledgement -- References -- Further reading -- ; 2. Nanostructured biomimetic, bioresponsive, and bioactive biomaterials / Kumar Mishra Raghvendra -- ; 2.1. Introduction -- ; 2.2. Nanostructured biomimetic materials -- ; 2.3. Nanostructured bioresponsive materials -- ; 2.4. Bioactive materials -- ; 2.5. Conclusion -- References -- ; 3. Micro- and nanopatterning of biomaterial surfaces / Pulickel M. Ajayan -- ; 3.1. Introduction -- ; 3.2. Photolithography -- ; 3.3. Soft lithography -- ; 3.4. Microcontact printing -- ; 3.5. Microfluidic patterning -- ; 3.6. Electron-beam lithography -- ; 3.7. Conclusion -- Acknowledgments -- References -- ; 4. Bioactive metallic surfaces for bone tissue engineering / P.N. Sudha -- ; 4.1. Introduction -- ; 4.2. Structural, physical, mechanical, and biological properties of metals -- ; 4.3. Designing metallic biomaterials -- ; 4.4. Applications of metallic biomaterials -- ; 4.5. Conclusion -- References -- ; 5. Metallic biomaterials for dental implant systems / Barnali Ghosh (Pal) -- ; 5.1. Introduction -- ; 5.2. Dental implant materials -- ; 5.3. Surface treatment of metal and alloy dental implants -- ; 5.4. Corrosion of metal and alloy dental implants -- ; 5.5. Zirconia as other alternative dental implant -- ; 5.6. Summary -- Acknowledgments -- References -- ; 6. Metallic biomaterial for bone support and replacement / Parag Sancheti -- ; 6.1. Metallic biomaterials in general -- ; 6.2. Properties of ideal metal -- ; 6.3. Conventional metallic implants -- ; 6.4. Generation of metallic biomaterials -- ; 6.5. Novel metallic biomaterials with enhanced bone support -- ; 6.6. Metal sensitivity -- ; 6.7. Future prospects -- ; 6.8. Conclusion -- References -- ; 7. Metals and alloys for biomedical applications / Mehar Al. Minnath -- ; 7.1. Introduction -- ; 7.2. Metallic biomaterials -- ; 7.3. Summary -- References -- ; 8. Biomaterials and biotechnological schemes utilizing TiO2 nanotube arrays -- A review / A.J. Sunija -- ; 8.1. Introduction -- ; 8.2. Synthesis of TiO2 NT arrays -- ; 8.3. Surface modification of TiO2 TN arrays -- ; 8.4. Factors influencing the properties of nanotube arrays -- ; 8.5. Applications -- ; 8.6. Conclusion -- ; 8.7. Scope of future work -- References -- Further reading -- ; 9. Surface modification of Magnesium and its alloy as orthopedic biomaterials with biopolymers / Mantravadi Krishna Mohan -- ; 9.1. Introduction -- ; 9.2. Biodegradable polymers -- ; 9.3. Summary and outlook -- References -- ; 10. Orthopedical and biomedical applications of titanium and zirconium metals / Suguna Lakshmi Madurai -- ; 10.1. Introduction -- ; 10.2. Bio-implantable materials in the late 20th century -- ; 10.3. Implants in 21st century -- ; 10.4. Modern era -- ; 10.5. Properties of an implant biomaterial -- ; 10.6. Medical applications and biocompatibility -- ; 10.7. Dentistry applications -- ; 10.8. Dental implants -- ; 10.9. Summary -- References -- Appendices -- ; 11. Porous tantalum: A new biomaterial in orthopedic surgery / Ajalesh B. Nair -- ; 11.1. Introduction -- ; 11.2. Tantalum -- ; 11.3. Porous tantalum -- ; 11.4. Clinical applications -- ; 11.5. Conclusion -- References -- ; 12. Titanium based bulk metallic glasses for biomedical applications / Arijit Sinha -- ; 12.1. Introduction -- ; 12.2. Bulk metallic glass -- ; 12.3. Titanium-based BMGs -- ; 12.4. Mechanical property of BMGs -- ; 12.5. Corrosion behavior of Ti-BMGs -- ; 12.6. Biomedical applications of Ti-based BMGs -- ; 12.7. Conclusion -- Acknowledgement -- References -- ; 13. Degradable metallic biomaterials for cardiovascular applications / P.N. Sudha -- ; 13.1. Introduction -- ; 13.2. Concept of degradation -- ; 13.3. Classes of biodegradable metals -- ; 13.4. Metals used in cardiovascular treatment -- ; 13.5. Future perspective -- ; 13.6. Conclusion -- References -- ; 14. Surface modification of metallic bone implants -- Polymer and polymer-assisted coating for bone in-growth / Arijit Sinha -- ; 14.1. Introduction -- ; 14.2. Biocompatibility and osseointegration -- ; 14.3. Porosity and metallic implant -- ; 14.4. Ideal properties of a coating material -- ; 14.5. Modified metallic implants with polymer and polymer assisted coatings -- ; 14.6. Electrospinning: a potential and less explored coating method for metallic implants -- ; 14.7. Proposed advanced modification methods for enhancing cell viability using bioinspired materials -- ; 14.8. Summary -- References -- ; 15. Biocompatible coatings for metallic biomaterials / Anitha Pius -- ; 15.1. Introduction -- ; 15.2. Biomaterials -- ; 15.3. Dental implants -- ; 15.4. Metallic biomaterials -- ; 15.5. Summary -- References -- ; 16. Enhancing the mechanical and biological performance of a metallic biomaterial for orthopedic applications / Shailendra Raghuwanshi -- ; 16.1. Introduction -- ; 16.2. Conclusion -- References -- ; 17. Interface influence of materials and surface modifications / Srividya Shivakumar -- ; 17.1. Introduction -- ; 17.2. PHA functionalization: the need -- ; 17.3. Functionalization of polyhydroxyalkanoates -- ; 17.4. Biomedical applications of PHAs -- ; 17.5. Conclusion -- References -- ; 18. Life cycle assessment of metallic biomaterials / A.R. Ajitha -- ; 18.1. Introduction -- ; 18.2. Different types of metallic biomaterials -- ; 18.3. Analysis of biocompatibility of metallic biomaterial -- ; 18.4. Conclusion -- References. |
| Record Nr. | UNINA-9910583027003321 |
| Duxford, Kidlington England ; ; Cambridge, Massachusetts : , : WoodHead Publishing, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Green composites / / Sabu Thomas and Preetha Balakrishnan (editors)
| Green composites / / Sabu Thomas and Preetha Balakrishnan (editors) |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XII, 617 p. 217 illus., 151 illus. in color.) |
| Disciplina | 660.0286 |
| Collana | Materials Horizons: From Nature to Nanomaterials |
| Soggetto topico |
Green chemistry
Biomedical materials |
| ISBN | 981-15-9643-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Green Composite using Agricultural Waste Reinforcement -- Green Composite as an Adequate Material for Automotive Applications -- Green Fiber Thermoplastic Composites -- Green Composites from Sustainable Cellulose Nanofibrils -- Green Composites -- Processing and Properties of Starch based Thermoplastic Matrix for Green Composites -- Lignin Nanoparticles and their Biodegradable Composites -- Recent Trends in Surface Modification of Natural Fibres for their Use in Green Composites -- Biodegradable Polymeric Materials for Medicinal Applications -- Applications of Biodegradable Green Composites -- Mechanical Properties of Flax-Cotton Fiber Reinforced Polymer Composites -- Green Composite film Synthesized from Agricultural Waste for Packaging Applications -- Green Composites for Application in Antistatic Packaging -- Green Preparation and Environmental Applications of Some Electrospun Fibers -- Green Composites from Medicinal Plants -- Molecular Imprinted Nanocomposites for Green Chemistry. |
| Record Nr. | UNINA-9910483684703321 |
| Gateway East, Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Handbook of nutraceuticals and natural products / / edited by Sreerag Gopi, Preetha Balakrishnan
| Handbook of nutraceuticals and natural products / / edited by Sreerag Gopi, Preetha Balakrishnan |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons Inc., , [2022] |
| Descrizione fisica | 1 online resource (937 pages) |
| Disciplina | 363.7288 |
| Soggetto topico |
Bioactive compounds
Dietary supplements Functional foods |
| ISBN |
1-119-74684-1
1-119-74683-3 1-119-74682-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Volume 1 -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface of Volume 1 -- Chapter 1 Introduction to Nutraceuticals and Natural Products -- 1.1 Introduction -- 1.2 Confrontation of Different Definitions of Nutraceuticals -- 1.3 Natural Bioactive Compounds (NBCs) -- 1.3.1 Classification of NBCs (Focusing on a Few Applications) -- 1.3.1.1 Natural Products from Plants (NPFPs) -- 1.3.1.2 Natural Products from Animals (NPFAs) -- 1.3.1.3 Microbial-based Products -- 1.3.2 Extraction of NBCs -- 1.4 Nutraceuticals and Their Role in Human Health -- 1.5 Types of Formulated Nutraceuticals -- 1.6 Combination of NBCs -- 1.6.1 Synergism and Beneficial Products -- 1.6.2 Antagonism and Detrimental Products -- 1.7 Quality of Nutraceuticals and Manufacturing Process -- 1.8 Biorefinery and Sustainable Source of Nutraceuticals -- 1.9 Encapsulation of Nutraceuticals -- 1.10 Nutraceuticals - Global Market Scenario -- 1.11 Regulations and Health Claims -- 1.12 Conclusion -- References -- Chapter 2 Functional Nutraceuticals: Past, Present, and Future -- 2.1 Introduction -- 2.1.1 Historical Perspective -- 2.1.1.1 History of Food and Sickness -- 2.1.1.2 History of Food as Medicine -- 2.1.1.3 The History of Functional Foods and Nutraceuticals -- 2.1.2 Functional Food and Nutraceutical Categories -- 2.2 Functional Food and Nutraceuticals: Where Are We Now? -- 2.2.1 The Functional Food and Nutraceutical Market -- 2.2.2 Functional Food and Nutraceuticals: Current Challenges -- 2.3 Functional Foods and Nutraceuticals: Future Perspectives -- 2.4 Conclusion -- References -- Chapter 3 Liposomal Nanotechnology in Nutraceuticals -- 3.1 Introduction -- 3.2 Definitions -- 3.3 Challenges of Nutraceutical Formulations -- 3.4 Nanoencapsulated Systems for the Food Industry -- 3.5 A Brief History of Liposomes -- 3.6 Uses of Liposomes in Food Products.
3.7 Nanoliposome Technology -- 3.7.1 Background -- 3.7.2 Advantages and Drawbacks: Liposomes vs. Nanoliposomes -- 3.7.3 Formulation and Specific Food Designs -- 3.7.4 Preparation Methods -- 3.7.5 Mechanism of Formation -- 3.7.6 Characterization -- 3.7.6.1 Particle Size -- 3.7.6.2 Zeta Potential -- 3.7.6.3 Structure and Morphology -- 3.7.6.4 Encapsulation Efficiency -- 3.7.7 Uses of Nanoliposomes in Nutraceutical Systems -- 3.7.8 Safety, Regulatory, and Sustainability Issues Related to Nanoliposomes -- 3.8 Future Trends -- 3.9 Conclusion -- Acknowledgments -- References -- Chapter 4 Bioavailability and Delivery of Nutraceuticals by Nanoparticles -- 4.1 Introduction -- 4.2 Constraints in Delivery of Nutraceuticals -- 4.3 Delivery Systems for Bioavailability Improvement of Nutraceuticals -- 4.4 Nanoparticle Delivery of Nutraceuticals -- 4.4.1 Organic Nanoparticles -- 4.4.1.1 Polymeric Nanoparticles -- 4.4.1.2 Lipid-based NPs -- 4.4.1.3 Protein-based Nanoparticles -- 4.4.2 Inorganic Nanoparticles -- 4.4.2.1 Mesoporous Silica Nanoparticles (MSNs) -- 4.4.2.2 Metal-based NPs -- 4.4.2.3 Metal Oxide-based Nanoparticles -- 4.5 Conclusion -- References -- Chapter 5 Prebiotics and Probiotics: Concept and Advances -- 5.1 Introduction -- 5.2 Probiotics -- 5.2.1 Therapeutic Benefits -- 5.2.1.1 Antioxidant Effects -- 5.2.1.2 Immune Modulation -- 5.2.1.3 Vitamins' Production -- 5.2.1.4 Metabolic Disorders -- 5.2.1.5 Psychiatric Disorders -- 5.2.1.6 Neurodegenerative Disorders -- 5.2.1.7 Gastrointestinal Disorders -- 5.2.1.8 Anti-infective Activities -- 5.2.2 Safety Concerns -- 5.3 Prebiotics -- 5.3.1 Health Impact -- 5.4 Synbiotics -- 5.5 Microencapsulation -- 5.6 Conclusion -- References -- Chapter 6 Marine Nutraceuticals -- 6.1 Introduction -- 6.2 Marine Bacteria and Fungi -- 6.3 Marine Algae -- 6.4 Marine Plants -- 6.5 Marine Animals -- 6.6 Conclusion. References -- Chapter 7 Nutraceuticals as Therapeutic Agents -- 7.1 Introduction -- 7.1.1 Definitions and Regulation of Nutraceuticals -- 7.1.2 Classification of Nutraceuticals -- 7.1.3 Pharmacology of Nutraceuticals and Functional Foods -- 7.1.3.1 Bioavailability of Nutraceuticals -- 7.1.3.2 Nutraceuticals: Active Principle -- 7.1.3.3 Nutraceuticals: Mechanism of Action -- 7.1.3.4 Nutraceuticals: Adverse Effects and Drug Interactions -- 7.2 Therapeutic Potential of Nutraceuticals -- 7.2.1 Nutraceuticals as Alternative or Add-on Therapies -- 7.2.2 Nutraceuticals as Therapeutic Agents - Future Perspectives -- References -- Chapter 8 Antioxidant Nutraceuticals as Novel Neuroprotective Agents -- 8.1 Introduction -- 8.2 Pathophysiological Effects of Oxidative Stress on Neurodegenerative Diseases -- 8.2.1 Synthesis of Reactive Oxygen Species (ROS) -- 8.2.2 Impacts of ROS at the Cellular Level -- 8.2.2.1 ROS and Oxidative Stress -- 8.2.2.2 Vulnerability of the Brain to Oxidative Stress -- 8.2.3 Oxidative Stress and Neurodegenerative Disorders -- 8.2.3.1 Oxidative Stress and Alzheimer's Disease (AD) -- 8.2.3.2 Oxidative Stress and Huntington's Disease (HD) -- 8.2.3.3 Oxidative Stress and Parkinson's Disease (PD) -- 8.2.3.4 Oxidative Stress and Amyotrophic Lateral Sclerosis (ALS) -- 8.2.3.5 Oxidative Stress and Spinocerebellar Ataxia (SCA) -- 8.3 Classification of Nutraceuticals -- 8.4 Potential Antioxidant Activity of Nutraceuticals in Neuroprotection -- 8.4.1 Alkaloids -- 8.4.1.1 Indole Alkaloids -- 8.4.1.2 Huperzine A -- 8.4.1.3 Aloperine -- 8.4.1.4 Alstonine -- 8.4.1.5 Berberine -- 8.4.1.6 Capsaicin -- 8.4.1.7 Galantamine -- 8.4.1.8 Piperine -- 8.4.2 Carotenoids -- 8.4.3 Flavonoid Polyphenols -- 8.4.3.1 Flavanols -- 8.4.3.2 Flavonols -- 8.4.3.3 Flavones -- 8.4.3.4 Isoflavones -- 8.4.3.5 Anthocyanidin -- 8.4.3.6 Flavanones. 8.4.4 Non-Flavonoid Polyphenols -- 8.4.4.1 Resveratrol -- 8.4.4.2 Curcumin -- 8.4.5 Phenolic Acid and Diterpenes -- 8.4.6 Probiotics -- 8.4.7 Prebiotics -- 8.4.8 Polyunsaturated Fatty Acid (PUFA) -- 8.4.9 Vitamin B -- 8.4.10 Creatine -- 8.4.11 Melatonin -- 8.5 Clinical Approach -- 8.6 Some Recent Trends in Nutraceutical-Related Research for Neurological Disorders -- 8.6.1 Role of MicroRNAs in Neurodegenerative Diseases -- 8.6.1.1 Alzheimer's Disease -- 8.6.1.2 Parkinson's Disease -- 8.6.1.3 Amyotrophic Lateral Sclerosis and Huntington's Disease -- 8.6.2 Nano-Formulation-Based Delivery of Natural Products -- 8.6.3 Future Neuroprotective Compounds -- 8.7 Present Research Gap and Future Prospective -- References -- Chapter 9 Flavonoids as Nutraceuticals -- 9.1 Nutraceuticals -- 9.2 Flavonoids -- 9.2.1 Structure and Classification of Flavonoids -- 9.2.2 Physicochemical and Pharmacokinetic Properties of Flavonoids -- 9.3 Pharmacological Actions -- 9.3.1 Antioxidant Activity -- 9.3.2 Anti-inflammatory Activity -- 9.3.3 Neuroprotective Activity -- 9.3.4 Antidiabetic Activity -- 9.3.5 Cardioprotective Activity -- 9.3.6 Antimicrobial Activity -- 9.3.7 Anticancer Activity -- 9.3.8 Hepatoprotective Activity -- 9.4 Conclusion -- References -- Chapter 10 Current Concepts and Prospects of Herbal Nutraceutical -- 10.1 Introduction -- 10.2 Global Market of Nutraceuticals -- 10.3 Classification of Nutraceutical Herbal Products -- 10.4 Health Benefits of Herbal-Based Nutraceuticals -- 10.5 Government Regulations -- 10.6 Future Scope for Herbal Nutraceuticals -- References -- Chapter 11 Lycopene as Nutraceuticals -- 11.1 Introduction -- 11.2 Sources of Lycopene -- 11.3 Disease-Preventive Nature of Lycopene -- 11.3.1 Antioxidant Properties -- 11.3.2 Anticarcinogenic Effect -- 11.3.2.1 Redox Activity. 11.3.2.2 Repression of Cancer Cell Proliferation and Apoptosis Induction -- 11.3.2.3 Involvement with Growth Factors' Stimulation of Cancer Cell Proliferation -- 11.3.2.4 Induction of Phase 2 Enzymes -- 11.3.2.5 Transcription Regulation -- 11.3.2.6 Modulation of Cytokine Expression -- 11.3.2.7 Invasion and Metastasis Inhibition -- 11.3.2.8 Improvement of Gap Junctional Communication -- 11.3.3 Antidiabetic Effect -- 11.3.4 Antihypertensive Effect -- 11.3.5 Effect on Cardiovascular Disease -- 11.3.6 Effect on Oxidative Stress -- 11.3.7 Other Diseases -- 11.4 Lycopene Extraction Method -- 11.5 Effect of Lycopene During Processing -- 11.6 Daily Intake of Lycopene -- 11.7 The Importance of Fortification -- 11.7.1 Mass Fortification -- 11.7.2 Targeted Fortification -- 11.7.3 Market-Driven fortification -- 11.8 Ongoing Fortification Process with Lycopene -- 11.9 Conclusion -- References -- Chapter 12 Nutraceutical Compounds from Marine Microalgae -- 12.1 Introduction -- 12.2 Marine Environment -- 12.3 Algae -- 12.4 Cyanobacteria -- 12.5 Microalgae -- 12.6 Cultivation Strategies of Microalgae -- 12.7 Conclusion -- Acknowledgments -- Conflict of Interest -- References -- Chapter 13 Polylysine: Natural Peptides as Antimicrobial Agents. A Recent Scenario in Food Preservation -- 13.1 Scenario of Food Spoilage Worldwide -- 13.2 Scenario of Food Spoilage in India -- 13.3 The Global Need for Food Preservation -- 13.4 Antimicrobial Packaging in Food Preservation -- 13.5 Antimicrobial Packaging with Bacteriocin -- 13.6 Polylysine as Antimicrobial Peptides in Food Preservation -- 13.6.1 Polylysine -- 13.6.2 Origin and Distribution of Polylysine -- 13.7 Antimicrobial Activity of Polylysine -- 13.8 Preservation Mechanism of -Polylysine -- 13.9 Polylysine on Major Food-Borne Pathogens -- 13.10 Global Market of -Poly-l-Lysine -- 13.11 Approval, Safety, and Regulations. 13.12 Food and Drug Administration (FDA). |
| Record Nr. | UNINA-9910585799603321 |
| Hoboken, New Jersey : , : John Wiley & Sons Inc., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanotechnology for biomedical applications / / Sreerag Gopi, Preetha Balakrishnan and Nabisab Mujawar Mubarak, editors
| Nanotechnology for biomedical applications / / Sreerag Gopi, Preetha Balakrishnan and Nabisab Mujawar Mubarak, editors |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore Pte Ltd., , [2022] |
| Descrizione fisica | 1 online resource (499 pages) |
| Disciplina | 610.28 |
| Collana | Materials horizons |
| Soggetto topico |
Biomedical engineering
Nanobiotechnology Nanomedicine |
| ISBN |
981-16-7482-5
981-16-7483-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910743345403321 |
| Singapore : , : Springer Nature Singapore Pte Ltd., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanotechnology for electronic applications / / Nabisab Mujawar Mubarak, Sreerag Gopi, Preetha Balakrishnan, editors
| Nanotechnology for electronic applications / / Nabisab Mujawar Mubarak, Sreerag Gopi, Preetha Balakrishnan, editors |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (270 pages) |
| Disciplina | 621.381 |
| Collana | Materials horizons |
| Soggetto topico | Nanoelectronics |
| ISBN |
981-16-6021-2
981-16-6022-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910743257203321 |
| Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||